Cryptococcal infections in two patients receiving ibrutinib therapy for chronic lymphocytic leukemia

Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis

(2017) Marine Baron et al.   LEUKEMIA & LYMPHOMA

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results

(2015) M. L. Wang et al.   BLOOD

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

(2013) John C. Byrd et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia

(2012) Tony Marchand et al.   LEUKEMIA & LYMPHOMA

Fatal Cryptococcal Meningitis in a Patient With Chronic Lymphocytic Leukemia

(2012) Oguzhan Sıtkı Dizdar et al.   Mediterranean Journal of Hematology and Infectious Diseases

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765

(2011) S. E. M. Herman et al.   BLOOD

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS